Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 2

Status

Completed 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6NETWORK 2OTHER_GOV 1NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 5Genitourinary 1

Conditions

Breast Neoplasms 3Risk Reduction Behavior 1Prostatic Neoplasms 1Hot Flashes 1Focus of Study is Healthy Women at Risk for Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × Estrogens, Conjugated (USP) × Clear all
NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

NCT04821375 2025-10-29

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed
16 enrolled
Breast

Breast Neoplasms

NCT02694809 2025-01-28

The PROMISE Study: Duavee in Women With DCIS

Northwestern University

Phase 2 Completed
142 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT02729701 2022-03-09

Pilot Study of the Effect of DuaveeĀ® on Benign Breast Tissue Proliferation

University of Kansas Medical Center

Phase 2 Completed
28 enrolled 9 charts
Breast

Breast Neoplasms

NCT04379024 2021-10-29

Pilot Study of Effects of DuaveeĀ® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

University of Kansas Medical Center

Phase EARLY_PHASE1 Terminated
11 enrolled
Breast

Focus of Study is Healthy Women at Risk for Breast Cancer

NCT00134654 2011-06-16

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔